Lim K, Loh A
Cancers (Basel). 2024; 16(17).
PMID: 39272909
PMC: 11393868.
DOI: 10.3390/cancers16173051.
Song L, Li Q, Xia L, Sahay A, Qiu Q, Li Y
Nat Commun. 2024; 15(1):5937.
PMID: 39009564
PMC: 11250843.
DOI: 10.1038/s41467-024-50171-w.
Fu W, Deng L, Yan X, Hua R, Zhang J, Zhou H
BMC Cancer. 2024; 24(1):772.
PMID: 38937681
PMC: 11209997.
DOI: 10.1186/s12885-024-12557-3.
Trink Y, Urbach A, Dekel B, Hohenstein P, Goldberger J, Kalisky T
Int J Mol Sci. 2024; 25(8).
PMID: 38674106
PMC: 11050615.
DOI: 10.3390/ijms25084520.
Xu W, Qu Q, Zhuang H, Teng X, Wei Y, Luo J
Int J Biol Sci. 2024; 20(5):1652-1668.
PMID: 38481812
PMC: 10929184.
DOI: 10.7150/ijbs.92988.
Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development.
Nirgude S, Naveh N, Kavari S, Traxler E, Kalish J
Br J Cancer. 2023; 130(4):638-650.
PMID: 38142265
PMC: 10876704.
DOI: 10.1038/s41416-023-02538-x.
Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis.
Pichavaram P, Jablonowski C, Fang J, Fleming A, Gil H, Boghossian A
Mol Cancer Ther. 2023; 23(4):478-491.
PMID: 37988559
PMC: 10987284.
DOI: 10.1158/1535-7163.MCT-23-0312.
Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor.
Stevenson M, Phanor S, Patel U, Gisselbrecht S, Bulyk M, OBrien L
Dis Model Mech. 2023; 16(11).
PMID: 37815464
PMC: 10668032.
DOI: 10.1242/dmm.050208.
Medical Genetics, Genomics and Bioinformatics-2022.
Klimontov V, Koshechkin K, Orlova N, Sekacheva M, Orlov Y
Int J Mol Sci. 2023; 24(10).
PMID: 37240312
PMC: 10219379.
DOI: 10.3390/ijms24108968.
Alterations of miRNA Expression in Diffuse Hyperplastic Perilobar Nephroblastomatosis: Mapping the Way to Understanding Wilms' Tumor Development and Differential Diagnosis.
Csok A, Micsik T, Magyar Z, Tornoczky T, Kuthi L, Nishi Y
Int J Mol Sci. 2023; 24(10).
PMID: 37240139
PMC: 10218489.
DOI: 10.3390/ijms24108793.
Retinoic acid promotes differentiation of WiT49- but not of CCG99-11 Wilms tumour cells.
Jansson C, Mengelbier L
Cancer Rep (Hoboken). 2023; 6(6):e1819.
PMID: 37186071
PMC: 10242656.
DOI: 10.1002/cnr2.1819.
Identification and Characterization of the Wilms Tumor Cancer Stem Cell.
Petrosyan A, Villani V, Aguiari P, Thornton M, Wang Y, Rajewski A
Adv Sci (Weinh). 2023; 10(20):e2206787.
PMID: 37114795
PMC: 10369255.
DOI: 10.1002/advs.202206787.
Characterization of the pattern of expression of Gas1 in the kidney during postnatal development in the rat.
Cetina-Palma A, Namorado-Tonix C, Rodriguez-Munoz R, Vergara P, Reyes-Sanchez J, Segovia J
PLoS One. 2023; 18(4):e0284816.
PMID: 37093844
PMC: 10124827.
DOI: 10.1371/journal.pone.0284816.
Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
Stoltze U, Hildonen M, Hansen T, Foss-Skiftesvik J, Byrjalsen A, Lundsgaard M
J Med Genet. 2023; 60(9):842-849.
PMID: 37019617
PMC: 10447365.
DOI: 10.1136/jmg-2022-108982.
Characterization of Continuous Transcriptional Heterogeneity in High-Risk Blastemal-Type Wilms' Tumors Using Unsupervised Machine Learning.
Trink Y, Urbach A, Dekel B, Hohenstein P, Goldberger J, Kalisky T
Int J Mol Sci. 2023; 24(4).
PMID: 36834944
PMC: 9965420.
DOI: 10.3390/ijms24043532.
Pathological consequences of DNA damage in the kidney.
Garaycoechea J, Quinlan C, Luijsterburg M
Nat Rev Nephrol. 2023; 19(4):229-243.
PMID: 36702905
DOI: 10.1038/s41581-022-00671-z.
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.
Pandya P, Jannu A, Bijangi-Vishehsaraei K, Dobrota E, Bailey B, Barghi F
Cancers (Basel). 2023; 15(1).
PMID: 36612255
PMC: 9818438.
DOI: 10.3390/cancers15010259.
Embryology and surgical anatomy of pediatric solid tumors.
Julson J, Beierle E
Semin Pediatr Surg. 2022; 31(6):151233.
PMID: 36423516
PMC: 10084944.
DOI: 10.1016/j.sempedsurg.2022.151233.
Characterization of alternative mRNA splicing in cultured cell populations representing progressive stages of human fetal kidney development.
Wineberg Y, Kanter I, Ben-Haim N, Pode-Shakked N, Bucris E, Bar-Lev T
Sci Rep. 2022; 12(1):19548.
PMID: 36380228
PMC: 9666651.
DOI: 10.1038/s41598-022-24147-z.
Hsa_circ_0093741 competes with FRS2 for miR-562 binding sites to promote nephroblastoma progression.
Yong J, He J, Ning F
Histol Histopathol. 2022; 38(5):559-570.
PMID: 36286392
DOI: 10.14670/HH-18-539.